GW Pharmaceuticals Cash/Share
What is the Cash/Share of GW Pharmaceuticals?
The Cash/Share of GW Pharmaceuticals is 14.53
What is the definition of Cash/Share?
Cash per share is a company’s cash on hand divided by the company’s shares outstanding.
mrq (most recent quarter)
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
Cash/Share of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with cash/share similar to GW Pharmaceuticals
- Valero has Cash/Share of 14.47
- Mohawk Industries has Cash/Share of 14.47
- adidas AG has Cash/Share of 14.50
- NXP Semiconductors N.V has Cash/Share of 14.51
- Liberty TripAdvisor has Cash/Share of 14.51
- GW Pharmaceuticals Plc has Cash/Share of 14.52
- GW Pharmaceuticals has Cash/Share of 14.53
- Vilmorin & Cie SA has Cash/Share of 14.54
- The Allstate has Cash/Share of 14.54
- Teekay Corp has Cash/Share of 14.54
- Fidelity China Special Situations Plc has Cash/Share of 14.55
- IM+ Capitals has Cash/Share of 14.56
- Manulife has Cash/Share of 14.56